PCI Biotech Holding ASA (LON:0JGL)
London
· Delayed Price · Currency is GBP · Price in NOK 1.680
0.00 (0.00%)
At close: Jun 16, 2025
PCI Biotech Holding ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 26.69 | 40.8 | 56.6 | 116.12 | 187.97 | Upgrade
|
| Cash & Short-Term Investments | 26.69 | 40.8 | 56.6 | 116.12 | 187.97 | Upgrade
|
| Cash Growth | -34.57% | -27.91% | -51.26% | -38.22% | -28.01% | Upgrade
|
| Other Receivables | 3.78 | 2.57 | 6.16 | 5.1 | 5.99 | Upgrade
|
| Receivables | 3.78 | 2.57 | 6.16 | 5.1 | 5.99 | Upgrade
|
| Prepaid Expenses | 0.06 | - | - | 7.1 | 7.18 | Upgrade
|
| Restricted Cash | 0.38 | 0.39 | - | - | - | Upgrade
|
| Other Current Assets | - | -0 | - | - | - | Upgrade
|
| Total Current Assets | 30.91 | 43.75 | 62.76 | 128.32 | 201.13 | Upgrade
|
| Property, Plant & Equipment | 0.31 | 0.3 | 0.72 | 7.66 | 7.99 | Upgrade
|
| Other Long-Term Assets | - | - | 0 | - | 0 | Upgrade
|
| Total Assets | 31.22 | 44.05 | 63.48 | 135.98 | 209.12 | Upgrade
|
| Accounts Payable | 1.72 | 0.71 | 0.5 | 3.75 | 5.19 | Upgrade
|
| Accrued Expenses | 5.71 | 3.94 | 4.82 | 15.93 | 13.98 | Upgrade
|
| Current Portion of Leases | 0.34 | 0.32 | 0.44 | 0.63 | 0.67 | Upgrade
|
| Other Current Liabilities | -0 | - | -0 | 0.61 | -0 | Upgrade
|
| Total Current Liabilities | 7.76 | 4.97 | 5.75 | 20.91 | 19.85 | Upgrade
|
| Long-Term Leases | - | - | 0.33 | 1.28 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.03 | - | - | 0.03 | Upgrade
|
| Total Liabilities | 7.76 | 5.01 | 6.08 | 22.19 | 19.88 | Upgrade
|
| Common Stock | 1.12 | 1.12 | 111.98 | 111.98 | 111.98 | Upgrade
|
| Additional Paid-In Capital | 22.33 | 37.92 | - | 450.46 | 450.46 | Upgrade
|
| Retained Earnings | - | - | -54.58 | -448.65 | -373.2 | Upgrade
|
| Comprehensive Income & Other | 0 | 0 | 0 | -0 | - | Upgrade
|
| Shareholders' Equity | 23.45 | 39.04 | 57.4 | 113.79 | 189.24 | Upgrade
|
| Total Liabilities & Equity | 31.22 | 44.05 | 63.48 | 135.98 | 209.12 | Upgrade
|
| Total Debt | 0.34 | 0.32 | 0.77 | 1.91 | 0.67 | Upgrade
|
| Net Cash (Debt) | 26.36 | 40.48 | 55.83 | 114.21 | 187.29 | Upgrade
|
| Net Cash Growth | -34.89% | -27.49% | -51.12% | -39.02% | -27.94% | Upgrade
|
| Net Cash Per Share | 0.71 | 1.08 | 1.50 | 3.06 | 5.02 | Upgrade
|
| Filing Date Shares Outstanding | 37.33 | 37.33 | 37.33 | 37.33 | 37.33 | Upgrade
|
| Total Common Shares Outstanding | 37.33 | 37.33 | 37.33 | 37.33 | 37.33 | Upgrade
|
| Working Capital | 23.14 | 38.78 | 57.01 | 107.41 | 181.28 | Upgrade
|
| Book Value Per Share | 0.63 | 1.05 | 1.54 | 3.05 | 5.07 | Upgrade
|
| Tangible Book Value | 23.45 | 39.04 | 57.4 | 113.79 | 189.24 | Upgrade
|
| Tangible Book Value Per Share | 0.63 | 1.05 | 1.54 | 3.05 | 5.07 | Upgrade
|
| Machinery | - | - | 10 | 10 | 9.66 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.